International Immunopharmacology

Elsevier BV

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

International Immunopharmacology is a journal published by Elsevier BV in Netherlands. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,130 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier BV
ISSN
1878-1705 · 1567-5769
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
3,130 USD
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2001-01-01
  • PUBMED · 2004-12-15
Indexing
MEDLINE · PUBMED
APC
3,130 USD
Declared review time (DOAJ)
—
Actual review time (measured)
84 days received→accepted — computed from PubMed (n=89)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

16397

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

166

i10-index

9359

From OpenAlex open data (CC0).

Editorial & policy3
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Open references deposited at Crossref
95%
ORCID iDs in current deposits
33%
Deposits licence metadata at Crossref
✓
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
100965259
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Immune Response and Inflammation
  • Immune Response and Inflammation
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • Immune cells in cancer
  • Immune cells in cancer
  • Inflammasome and immune disorders
  • Inflammasome and immune disorders
Show all subjects (50)
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Ferroptosis and cancer prognosis
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Ferroptosis and cancer prognosis
  • T-cell and B-cell Immunology
  • T-cell and B-cell Immunology
  • NF-κB Signaling Pathways
  • NF-κB Signaling Pathways
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Cytokine Signaling Pathways and Interactions
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Cytokine Signaling Pathways and Interactions
  • Natural product bioactivities and synthesis
  • Natural product bioactivities and synthesis
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Tryptophan and brain disorders
  • Tryptophan and brain disorders
  • Pharmacological Effects of Natural Compounds
  • interferon and immune responses
  • Pharmacological Effects of Natural Compounds
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • interferon and immune responses
  • Dermatology and Skin Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Diverse Scientific and Economic Studies
  • Rheumatoid Arthritis Research and Therapies
  • Diverse Scientific and Economic Studies
  • Dermatology and Skin Diseases
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Autophagy in Disease and Therapy
  • Autophagy in Disease and Therapy
  • Extracellular vesicles in disease
  • Extracellular vesicles in disease

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: